Page last updated: 2024-09-05

sb 216763 and Lung Injury, Acute

sb 216763 has been researched along with Lung Injury, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham, E; Inoki, K; Jiang, S; Liu, Y; Park, DW; Siegal, GP; Zmijewski, JW1

Other Studies

1 other study(ies) available for sb 216763 and Lung Injury, Acute

ArticleYear
GSK3β-dependent inhibition of AMPK potentiates activation of neutrophils and macrophages and enhances severity of acute lung injury.
    American journal of physiology. Lung cellular and molecular physiology, 2014, Nov-15, Volume: 307, Issue:10

    Topics: Acute Lung Injury; AMP-Activated Protein Kinases; Animals; Cell Line; Chemokine CXCL2; Chromones; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HMGB1 Protein; I-kappa B Kinase; Indoles; Lipopolysaccharides; Macrophage Activation; Macrophages; Maleimides; Mice; Morpholines; Neutrophil Activation; Neutrophils; Phosphorylation; Pulmonary Edema; Tumor Necrosis Factor-alpha

2014